Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leslie Citrome

Showing results (1-10 of 441) with videos related to

Pageof 45
Sort By:
Expert Opinion on Drug Safety|February 22, 2011
Drug safety evaluation of ziprasidoneLeslie Citrome
Postgraduate Medicine|August 3, 2010
Adjunctive aripiprazole, olanzapine, or quetiapine for major depressive disorder: an analysis of number needed to treat, number needed to harm, and likelihood to be helped or harmedLeslie Citrome
Current Medical Research and Opinion|November 29, 2023
Artificial Intelligence and the potential for Garbage In, Garbage OutLeslie Citrome
Journal of the Neurological Sciences|March 10, 2018
Reprint of: Clinical management of tardive dyskinesia: Five steps to successLeslie Citrome
International Journal of Clinical Practice|March 6, 2018
Perspectives, Commentaries, Consensus Reports, Grand Rounds, Meta-Analyses, Systematic Reviews, Narrative Reviews: Collecting useful information in one placeLeslie Citrome
International Journal of Clinical Practice|October 7, 2017
Reducing harms: Focus on drug-drug interactions and adverse drug eventsLeslie Citrome
Evidence-Based Mental Health|July 27, 2006
Maintenance treatment with olanzapine reduces relapse in people with bipolar I disorder who have responded to acute olanzapine treatmentLeslie Citrome
Clinical Therapeutics|May 7, 2020
Consider Clinical Therapeutics for Your Next Psychiatry SubmissionLeslie Citrome
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|July 31, 2004
Re: treatment noncompliance with orally disintegrating olanzapine tabletsLeslie Citrome
CNS Spectrums|June 15, 2019
Binge eating disorder revisited: what's new, what's different, what's nextLeslie Citrome
Pageof 45

Showing results (1-10 of 441) with videos related to

Sort By:
Pageof 45
Expert Opinion on Drug Safety|February 22, 2011
Drug safety evaluation of ziprasidoneLeslie Citrome
Postgraduate Medicine|August 3, 2010
Adjunctive aripiprazole, olanzapine, or quetiapine for major depressive disorder: an analysis of number needed to treat, number needed to harm, and likelihood to be helped or harmedLeslie Citrome
Current Medical Research and Opinion|November 29, 2023
Artificial Intelligence and the potential for Garbage In, Garbage OutLeslie Citrome
Journal of the Neurological Sciences|March 10, 2018
Reprint of: Clinical management of tardive dyskinesia: Five steps to successLeslie Citrome
International Journal of Clinical Practice|March 6, 2018
Perspectives, Commentaries, Consensus Reports, Grand Rounds, Meta-Analyses, Systematic Reviews, Narrative Reviews: Collecting useful information in one placeLeslie Citrome
International Journal of Clinical Practice|October 7, 2017
Reducing harms: Focus on drug-drug interactions and adverse drug eventsLeslie Citrome
Evidence-Based Mental Health|July 27, 2006
Maintenance treatment with olanzapine reduces relapse in people with bipolar I disorder who have responded to acute olanzapine treatmentLeslie Citrome
Clinical Therapeutics|May 7, 2020
Consider Clinical Therapeutics for Your Next Psychiatry SubmissionLeslie Citrome
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|July 31, 2004
Re: treatment noncompliance with orally disintegrating olanzapine tabletsLeslie Citrome
CNS Spectrums|June 15, 2019
Binge eating disorder revisited: what's new, what's different, what's nextLeslie Citrome
Pageof 45